Literature DB >> 29341916

Effects of surfactant-based permeation enhancers on mannitol permeability, histology, and electrogenic ion transport responses in excised rat colonic mucosae.

Sam Maher1, Joanne Heade2, Fiona McCartney2, Seona Waters3, Sinéad B Bleiel4, David J Brayden2.   

Abstract

Surfactant-based intestinal permeation enhancers (PEs) are constituents of several oral macromolecule formulations in clinical trials. This study examined the interaction of a test panel of surfactant-based PEs with isolated rat colonic mucosae mounted in Ussing chambers in an attempt to determine if increases in transepithelial permeability can be separated from induction of mucosal perturbation. The aim was to assess the effects of PEs on (i) apparent permeability coefficient (Papp) of [14C]-mannitol (ii) histology score and (iii) short-circuit current (ΔIsc) responses to a cholinomimetic (carbachol, CCh). Enhancement ratio increases for Papp values followed the order: C10 > C9 = C11:1 > a bile salt blend > sodium choleate > sucrose laurate > Labrasol® >C12E8 > C12 > Cremophor® A25 > C7 > sucrose stearate > Kolliphor® HS15 > Kolliphor® TPGS. Exposures that increased the Papp by ≥2-fold over 120 min were accompanied by histological damage in 94% of tissues, and by a decreased ΔIsc response to CCh in 83%. A degree of separation between the increased Papp of [14C]-mannitol and histological damage and diminution of the ΔIsc response to CCh was observed at selected concentrations of Labrasol®. Overall, this surfactant-based PE selection caused transcellular perturbation at similar concentrations to those that enhanced permeability.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Intestinal epithelial damage; Intestinal permeation enhancers; Surfactant toxicity; Ussing chamber

Mesh:

Substances:

Year:  2018        PMID: 29341916     DOI: 10.1016/j.ijpharm.2018.01.008

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  9 in total

Review 1.  A Critical Overview of the Biological Effects of Excipients (Part II): Scientific Considerations and Tools for Oral Product Development.

Authors:  Marilyn N Martinez; Fang Wu; Balint Sinko; David J Brayden; Michael Grass; Filippos Kesisoglou; Aaron Stewart; Kiyohiko Sugano
Journal:  AAPS J       Date:  2022-05-02       Impact factor: 4.009

2.  Synthesis, Structure⁻Activity Relationships and In Vitro Toxicity Profile of Lactose-Based Fatty Acid Monoesters as Possible Drug Permeability Enhancers.

Authors:  Simone Lucarini; Laura Fagioli; Robert Cavanagh; Wanling Liang; Diego Romano Perinelli; Mario Campana; Snjezana Stolnik; Jenny K W Lam; Luca Casettari; Andrea Duranti
Journal:  Pharmaceutics       Date:  2018-07-03       Impact factor: 6.321

3.  The In Vivo Effect of Transcellular Permeation Enhancers on the Intestinal Permeability of Two Peptide Drugs Enalaprilat and Hexarelin.

Authors:  David Dahlgren; Markus Sjöblom; Mikael Hedeland; Hans Lennernäs
Journal:  Pharmaceutics       Date:  2020-01-26       Impact factor: 6.321

4.  Evaluation of Sucrose Laurate as an Intestinal Permeation Enhancer for Macromolecules: Ex Vivo and In Vivo Studies.

Authors:  Fiona McCartney; Mónica Rosa; David J Brayden
Journal:  Pharmaceutics       Date:  2019-10-31       Impact factor: 6.321

5.  Impact of Intestinal Concentration and Colloidal Structure on the Permeation-Enhancing Efficiency of Sodium Caprate in the Rat.

Authors:  Staffan Berg; Lillevi Kärrberg; Denny Suljovic; Frank Seeliger; Magnus Söderberg; Marta Perez-Alcazar; Natalie Van Zuydam; Bertil Abrahamsson; Andreas M Hugerth; Nigel Davies; Christel A S Bergström
Journal:  Mol Pharm       Date:  2021-12-20       Impact factor: 4.939

6.  In Silico-Based Experiments on Mechanistic Interactions between Several Intestinal Permeation Enhancers with a Lipid Bilayer Model.

Authors:  Rosita Kneiszl; Shakhawath Hossain; Per Larsson
Journal:  Mol Pharm       Date:  2021-12-16       Impact factor: 4.939

Review 7.  Safety and Toxicity Issues of Therapeutically Used Nanoparticles from the Oral Route.

Authors:  Farzaneh Lotfipour; Shahriar Shahi; Afsaneh Farjami; Sara Salatin; Mohammad Mahmoudian; Solmaz Maleki Dizaj
Journal:  Biomed Res Int       Date:  2021-10-28       Impact factor: 3.411

Review 8.  Intestinal Absorption Study: Challenges and Absorption Enhancement Strategies in Improving Oral Drug Delivery.

Authors:  Maisarah Azman; Akmal H Sabri; Qonita Kurnia Anjani; Mohd Faiz Mustaffa; Khuriah Abdul Hamid
Journal:  Pharmaceuticals (Basel)       Date:  2022-08-08

Review 9.  Advanced delivery strategies facilitating oral absorption of heparins.

Authors:  Guihua Fang; Bo Tang
Journal:  Asian J Pharm Sci       Date:  2020-01-09       Impact factor: 6.598

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.